Unknown

Dataset Information

0

Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.

ABSTRACT: Ceftolozane/tazobactam: a new option in the treatment of complicated gram-negative infections.

SUBMITTER: Sorbera M 

PROVIDER: S-EPMC4264669 | biostudies-other | 2014 Dec

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.

Sorbera Maria M   Chung Elizabeth E   Ho Christopher W CW   Marzella Nino N  

P & T : a peer-reviewed journal for formulary management 20141201 12

Ceftolozane/tazobactam: a new option in the treatment of complicated gram-negative infections. ...[more]

Similar Datasets

Unknown Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
| S-EPMC7179316 | biostudies-literature
Unknown Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections.
| S-EPMC4461093 | biostudies-literature
Unknown Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections.
| S-EPMC4878668 | biostudies-literature
Unknown In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates.
| S-EPMC6055570 | biostudies-other
Unknown Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019.
| S-EPMC7936229 | biostudies-literature
Unknown In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.
| S-EPMC6105828 | biostudies-literature
Unknown Ceftolozane-Tazobactam Combination Therapy Compared to Ceftolozane-Tazobactam Monotherapy for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis.
| S-EPMC7830767 | biostudies-literature
Unknown Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients.
| S-EPMC7767535 | biostudies-literature
Unknown Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections.
| S-EPMC6535558 | biostudies-literature
Unknown Failure of ceftolozane-tazobactam salvage therapy in complicated pneumonia with lung abscess.
| S-EPMC6028400 | biostudies-literature